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Background: Contraceptive security is crucial in ensuring access to family planning services and improving the 
contraceptive prevalence rate. This requires proper forecasting and procurement of contraceptives. It is therefore 
important to study consumption patterns and apply forecasting techniques so as to adjust for any changes in the 
choice of contraceptives over a given time period. 
Objectives: The objectives of this study were to analyze trends, identify any seasonal or cyclic patterns in 
consumption of contraceptives, compare service point and consumption data, forecast consumption for six months 
and determine optimal models for forecasting contraceptives. 
Methods: Data on consumption of implants, injectables, pills, and Intrauterine Contraceptive Devices (IUCDs) were 
extracted from the Kenya District Health Information System for the years 2014-2018. An exploratory analysis was 
done and the data decomposed to evaluate the trends and seasonal components. Service point and consumption data 
of contraceptives were compared. Short-term forecasting using the Autoregressive Integrated Moving Average 
(ARIMA) and the Exponential Smoothing (ES) models was done. The optimal model for forecasting was determined 
and the models validated using actual facility consumption data for 2018. 
Results: The consumption of pills, injectables, and IUCDs declined while that of implants increased significantly 
across the 4 years. There were differences in the data reported for consumption and service point data for injectables, 
implants, and IUCDs. The ES models recorded the least error when forecasting consumption of all contraceptives 
except for one-rod implants in which the ARIMA model had the least errors. 
Conclusion: There was a general shift towards the use of long-acting reversible methods especially implants in Kenya. 
The difference in the reporting of consumption and service point data for injectables, implant, and IUCDs showed gaps 
in the documentation and reporting of contraceptives. The ETS models were generally superior to the ARIMA models 
for predicting consumption of contraceptives. 
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1. Introduction 
Family planning (FP) is the practice of regulating the 
number of children born and the spacing interval 
between them by use of modern or traditional methods. 
Promotion of FP practices, the supply of preferred 
contraceptives and services for women and couples is 
essential in improving the wellbeing and freedom of 
women (World Health Organization, 2016). In Kenya, 
the most commonly used modern contraceptive 
methods are Combined Oral Contraceptives (COCs), 
Progestin-Only Pills (POPs), injectables, one and two-
rod implants and Intrauterine Contraceptive Devices 
(IUCDs) (Kenya National Bureau of Statistics, 2014).  
Kenya, like many developing countries in sub-Saharan 
Africa, faces various challenges that hinder proper 
quantification and procurement of contraceptives. This 
includes inaccurate data on consumption, lack of 
technical know-how, improper method mix, inadequate 
financing, and over-dependence on donor funding. 
Some of the consequences of improper quantification 
are stock-outs, expiries, unsatisfied clients, reduced 
Contraceptive Prevalence Rate (CPR) and increased 
unmet FP needs. Shortages of contraceptives are seen as 
one of the leading causes of discontinuation of 
contraceptives and a reason for turning away clients by 
health care providers (Douglas-Durham et al, 2015). 
Lack of contraceptives in health facilities can result 
from expiries or stock-outs. Stock-outs are experienced 
commonly in health facilities providing FP services from 
time to time and at varying levels (Ministry of Health 
Kenya, 2018). Lack of these contraceptives limits 
accessibility to the desired choice of contraceptives by 
women and contributes to the unmet need for 
contraception (Sedgh and Hussain, 2014). Studying 
trends in consumption of contraceptives lead to the 
procurement of appropriate quantities that minimizes 
waste due to expiries, stocks outs as well as drops in 
consumption. Comparison of service statistics and 
consumption levels is key in ensuring proper 
management of the contraceptives and the quality of 
reporting.  
The aim of the study was to analyze the consumption of 
contraceptives (pills, injectables, IUCDs, and implants) 
in the public sector from the year 2014 to 2017 to 
identify trends and seasonal patterns. Data collected at 
the service point and consumption levels of the 
contraceptives were compared to check for similarities. 
The study also forecasted consumption for six months 
and actual data from January to June 2018 was used to 
validate the forecasts. The optimal models for 
forecasting the contraceptives were also determined. 
2. Methods 
2.1 Study design 
The study design was a time series analysis of 
contraceptive consumption. The study applied time 
series forecasting techniques on monthly consumption 
of pills, implants, IUCDs, and injectables in Kenya. The 
study population was women of reproductive age (15-
49 years) using contraceptives in the public sector and 
faith-based organizations whose consumption was 
reported through the District Health Information 
System (DHIS2) database. 
2.2 Data retrieval 
Aggregate data on the use of female contraceptives 
(implants, IUCDs, pills, and injectables) in Kenya public 
Sector was collected from DHIS2 for the years 2014, 
2015, 2016, 2017 and 2018 The study utilized data on 
dispensed products from the Facility Contraceptive 
Consumption Report and Request (FCCRR) form and 
MOH 711 Integrated Summary Report (Reproductive 
and Child Health, Medical and Rehabilitation services) 
for number of clients receiving each type of 
contraceptive (service point data). To improve 
forecasting, data cleaning was done to mitigate 
incomplete data sets.  
The reporting rates for contraceptives consumption 
varied from month to month during the study period. 
The average reporting rate for contraceptive 
consumption was 63.1 % representing 4795 health 
facilities reports out of 7882 expected reports. The data 
was transformed to reflect a 100% reporting rate. Data 
accuracy could not be verified from the primary facility 
hence a study limitation. 
2.3 Exploratory analysis 
Visual inspection of the time series graphs for each 
contraceptive was done to check for trend, stationarity, 
and seasonality. An augmented Dickey-Fuller test was 
also conducted to test for stationarity. For non-
stationary series, differencing was done to transform it 
to stationarity. The Auto-Correlation Function (ACF) 
and the partial ACF graphs were plotted as well as the 
Ljung-Box test to test for the presence of 
autocorrelation. The data were log-transformed to 
remove any autocorrelation and to ensure the 
consumption data fitted with an additive model. Each of 
the contraceptives trend and seasonal components 
were plotted separately and described.  
2.4 Forecasting of consumption data 
A short-term forecast for demand for contraceptives 
was done using Exponential Smoothing (ES) and 
Autoregressive Integrated Moving Average (ARIMA) 
methodologies and their predictive accuracies were 
compared. The forecast was done for six months (h =6). 
The 95% prediction interval for the forecast was 
computed and plotted for each of the ES and ARIMA 
methods. The forecast errors for the consumption data 
(training data) and validation data (test data) were also 
determined. 
Cross-validation and comparison of the models 
The reported data for all contraceptives from January to 
June 2018 (test data) was compared with the point 
forecasts for the same period to determine how well the 
models forecasted the family planning consumption 
data. 
The Ljung-Box test and Shapiro Wilk test were used to 
check for autocorrelations and normality in forecast 
errors respectively. To come up with the most 
parsimonious fit, Root Mean Squared Errors (RMSE), 
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Mean Absolute Scale Errors (MASE), and Mean Absolute 
Percentage Errors (MAPE) were used. 
 
2.5 Ethical approval 
Approval to use the DHIS2 data for contraceptives was 
sought from the Ministry of Health, Department of 
Health Care Financing, Policy and Planning and Health 
Information Systems Unit. The study utilized aggregate 
data with no unique identifiers for clients; therefore, it 
was a minimal risk study. However, approval to carry 
out the study was sought from the Kenyatta National 
Hospital/University of Nairobi Ethics and Research 
Committee (KNH-UON-ERC). The ethics approval was 
given on 5th March 2018 and the reference number was 
P714/12/2017.  
3. Results  
The yearly proportion of women who received COCs 
and injectables declined from 2014 to 2017 while those 
on implants and IUCDs increased. Most women seeking 
FP services used injectables (66.5%) followed by COCs 
(12.7%), implants (12.2%), IUCDs (4.5%) and lastly 
progestin-only pills (4.1%). This is presented in Table 
1. 
  Table 1: The Yearly Proportion of Women Using Various Contraceptives from 2014 to 2017 
 The proportion of women who received each family planning commodity (%) 
Year 
Combined oral 
contraceptives 
Progestin-
only pills 
Injectables 
 
Implants 
Intrauterine 
contraceptive devices 
2014 14.7 3.5 69.9 9.1 2.8 
2015 14.1 3.9 67.3 11.7 2.9 
2016 12.7 4.6 64.8 12.4 5.5 
2017 9.1 4.4 64.1 15.5 6.9 
Average  12.7 4.1 66.5 12.2 4.5 
 
Figure 1: Time plots for consumption and service point data for combined oral contraceptives, progestin-only pills, 
and Injectables 
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Exploratory analysis of the contraceptive 
consumption and service point data 
The time series plots of COC’s, POPs, injectables 
consumption (Figure 1 a, c, and e) showed a decline in 
consumption from 2014 to 2017. The lowest 
consumption of these contraceptives was in July and 
August 2017. The consumption of COCs (Figure1 a) had 
high consumption in April 2014 and January 2015. The 
highest consumption of POPs (Figure 1 c) was in 
August and October 2015. The highest consumption for 
injectables was in February 2014, towards the end of 
2016 and 2017 as seen in Figure 1 (e). The service 
point consumption for COCs, POPs and injectables also 
decreased from 2014 to 2017 (Figure 1 b, d, and f) 
respectively. 
There was increased consumption of IUCDs from mid to 
the end of 2014 and a slight increase at the beginning of 
2017 (Figure 2a) and the lowest consumption was 
towards the end of 2017. One and two-rod implants had 
an increasing trend in consumption from 2014 to 2017 
(Figure 2c). The lowest consumption for implants was 
in June 2017. The service point consumption data for 
IUCDs decreased from 2014 to 2017 while that of 
implants was erratic and showed a slight increase. 
 
Figure 2: Time Plots for Consumption and Service Point Data for Intrauterine Contraceptives Devices and Implants 
 
Evaluation of the trends in consumption of 
contraceptives  
The consumption of IUCDs, injectables and combined 
oral contraceptives has been on the decline since 2014 
as presented in Figure 3. For implants and POPs, there 
was an increase in consumption followed by a decline 
from 2014 to 2017. 
Evaluation of seasonal patterns in the consumption 
of contraceptives 
The consumption of contraceptives had periods of high 
and low consumption as presented in Figure 4. The 
consumption for COCs was the highest in January; other 
high periods were in September and October while the 
lowest periods of consumption were in April, 
November, and December. The POPs had the highest 
periods of consumption in August and October while 
the lowest consumption was in December. The one-rod 
implants had the highest consumption in July and the 
lowest consumption was in June and December. The 
two-rod implants had the highest consumption in 
March and September while the lowest consumption 
was in June and December. The injectables had the 
highest consumption in January and December while 
the lowest was in June and August. For IUCDs, the 
highest consumption was in April, August, and 
November while the lowest was in February and June. 
Comparison of service point data and consumption 
data of contraceptives 
The reported consumption and service data for 
injectables were relatively similar while that of implants 
and IUCDs differed significantly as presented in Figure 
5. 
Forecasting consumption of contraceptives  
The training and test data fit parameters were 
examined to compare forecast accuracies of different 
models as presented in Table 2. The Mean Absolute 
Error (MAE), the Root Mean Squared Error (RMSE) and 
the Mean Absolute Percentage Error (MAPE) were used 
to compare the forecast errors of the forecasting models 
for each of the contraceptives. 
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Figure 3: The trend components from 2014 to 2017 for each contraceptive 
 
Figure 4: The Seasonal components for contraceptives consumption from 2014 to 2017 
 
Karanja et al, Afr. J. Pharmacol. Ther. 2020. 9(1): 9-17 
 
A KeSoBAP Publication ©2020. All rights reserved. 
14 
Key- Black represents consumption data while red represents the service point data 
Figure 5: Comparison of the Consumption and Service Point Data for Implants, Intrauterine Contraceptive Devices, 
and Injectables. 
 
Table 2: Forecast Errors for the ARIMA and Exponential Smoothing Models for Each Contraceptive 
  MODEL ME RMSE MAE MPE MAPE ACF1 Theil's U 
POP 
  
ARIMA(0,1,1) -0.109 0.115 0.109 -1.073 1.073 0.265 3.073 
ETS (M,N,N) -0.092 0.099 0.092 -0.902 0.902 0.230 2.739 
COC 
  
ARIMA(1,1,0) 
with drift 
0.305 0.370 0.305 2.696 2.696 0.581 2.617 
ETS (A,N,N) 0.136 0.212 0.157 1.191 1.387 0.536 1.511 
IUCD 
  
ARIMA(0,1,1) -0.054 0.288 0.249 -0.621 2.495 0.267 0.911 
ETS(M,N,N -0.054 0.288 0.249 -0.625 2.495 0.267 0.912 
Injectables 
  
ARIMA(5,1,0) 
with drift 
0.238 0.289 0.238 1.928 1.928 0.125 3.662 
ETS(A,N,N) -0.117 0.128 0.117 -0.949 0.949 -0.300 1.555 
One rod 
Implants 
  
ARIMA(1,1,3) 0.048 0.066 0.059 0.447 0.553 -0.354 0.702 
ETS M,N,N -0.065 0.090 0.072 -0.611 0.676 -0.375 1.021 
Two-rod 
Implants 
  
ARIMA(0,1,1) 0.093 0.103 0.093 0.910 0.910 -0.061 1.392 
ETS(A,A,N) 0.052 0.068 0.052 0.502 0.502 -0.236 0.802 
Key: ME-Mean Error, RMSE-Root Mean Squared Error, MAE-Mean Absolute Error, MPE-Mean Percentage Error, MAPE- Mean 
Absolute Percentage Error and ACF-Autocorrelation coefficient, ETS –Error, Trend, and Seasonality for exponential smoothing 
models. 
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The most optimal model for POPs was the ETS (M, N, N) 
because it reported the lowest value for MAE, RMSE and 
the MAPE. This model tended to underestimate 
consumption because the mean error (-0.092) and 
mean percentage error (-0.902) were negative (Figure 
6). 
Figure 6: Comparison between actual consumption 
(black) and forecasted consumption (red) for POPs and 
COCs using exponential smoothing method 
 
For COCs, the ETS (A, N, N) model was the most optimal 
and performed better than ARIMA (0,1,1) model 
because the RMSE, MAE, and MPE for the ETS model 
were about half those of ARIMA model (Figure 6). For 
the ES model, the mean error and mean percentage 
error were positive indicating that the forecasts were 
overestimates of actual consumption in 2018. 
The most optimal model for intrauterine contraceptive 
devices was ETS (M, N, N), however, with regards to the 
measures of accuracy, the ARIMA model (0,1,1) 
performed similarly to the ETS model and had similar 
RMSE and MAE values. Both models also 
underestimated the consumption because the mean 
error was -0.054 (Figure 7).  
Figure 7: Comparison between actual consumption 
(black) and forecasted consumption (red) for IUCDs and 
injectables using the exponential smoothing method. 
 
The best model for injectables was ETS (A, N, N) 
whereby the forecast error statistics were far less than 
those for ARIMA (5,0,1) model. The forecasts for 
injectables were less than the actual values of validation 
data because the mean error was -0.117 (Figure 7). 
For two-rod implants, the optimal model was ETS (A, A, 
N) and the forecasts were overestimated with a mean 
error of 0.052. The only contraceptive for which the 
ARIMA model was better than the ES model was the 
one-rod implants. The ARIMA (1,1,3) model had a mean 
error of 0.048, which was the smallest indicating that it 
gave a very good forecast even though the forecasts 
tended to overestimate the actual consumption (Figure 
8). 
Figure 8: Comparison between actual consumption 
(black) and forecasted consumption (red) for one rod 
implants using ARIMA and two rod implants using 
exponential smoothing methods. 
 
Model diagnostics 
Model diagnostics were done for each of the forecasting 
models. The residuals for all contraceptives were not 
auto-correlated with either model. The residuals of the 
selected models for POPs, IUCDs, and one-rod implants 
were normally distributed except for COC, injectables, 
and two-rod implants. Lack of normal distribution of 
residuals was an indication that the model could be 
improved. The models were acceptable because the 
residuals were not autocorrelated. 
4.0 Discussion 
The use of COCs, injectables, and IUCDs steadily 
declined while that of implants increased from 2014 to 
2017. The use of progestin-only pills increased up to 
2015 then declined in 2016 and 2017. The decline could 
have been attributed to a shift towards the use of long-
term reversible methods especially implants. There 
were advocacy programs run by various organizations 
prior to the review period. The Kenya Urban 
Reproductive Health Initiative (Tupange program), an 
initiative by the government and various organizations 
ended in 2014 and resulted in the rise of the use of long-
term methods especially implants in 2014 and a 
reduction in the use of injectables and pills as compared 
to the baseline (2010). The Tupange program targeted 
the urban poor areas in Nairobi, Kakamega, Mombasa, 
Kisumu and Machakos counties for women of 15 to 49 
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years of age so as to increase modern contraceptives 
use (Kenya Urban Reproductive Health Initiative et al, 
2014a, 2014b, 2015). 
The rise in the use of implants could also be associated 
to the launch of the Implant Access Program in 2013 
where a group of private and public organizations 
collaborated with manufacturers, Bayer and Merck, to 
ensure access to implants such as Jadelle®, Implanon® 
and Implanon NXT® to poor countries through reduced 
prices of up to 50%. Kenya was a beneficiary of Implant 
Access Program and was among the countries with the 
highest procurement of implants in 2015 (Sergison et 
al., 2017). As part of the Implant Access program, the 
best practice training and implementation were 
conducted in Kilifi and Migori counties (Sergison et al., 
2017). An easier to insert and remove one-rod implant 
(Implanon NXT®) was piloted in Kenya in 2015 and 
rolled out in 2016 (MSD, 2018; United Nation 
Foundation, 2018). 
The proportion of women seeking family planning 
services declined from 29.7 to 18.5% over the four 
years. This was consistent with the Performance, 
Monitoring, and Accountability Survey (PMA 2020), 
which was done in 2016 (round five) by the Ministry of 
Health, Kenya in collaboration with various 
organizations in eleven counties. The survey showed a 
reduction in the modern methods contraceptive 
prevalence rate from 46.0 in 2015 to 44.2% in 2016 
(Ministry of Health Kenya, 2017). 
The PMA 2020 survey in 2016 showed similar trends in 
the utilization of contraceptives (Ministry of Health 
Kenya, 2017). There was an increase in the 
consumption of implants from 23.4 to 25.5% and then 
to 30.2% from round three, four and five respectively 
among married women. The injectables reduced from 
50.1 to 46.2% then to 46.0% over the same period. The 
pills (COCs and POPs) use among married women also 
reduced from 12.3 to 11.9% then to 8.5 % from round 
three, four to five respectively (Ministry of Health 
Kenya, 2017). 
There were notable peaks in the consumption of COCs, 
POPs IUCDs and implants. These periods of high 
consumption were associated with low stock out levels 
in the providing facilities (Ministry of Health Kenya, 
2018). The erratic pattern in consumption of POP’s 
could be explained by frequent stock-outs and erratic 
supply of the contraceptives. The percentage of women 
in Kenya using IUCDs was relatively low at 3.4 % in 
2014 (Kenya National Bureau of Statistics, 2014). A 
study done in two Nairobi public hospitals showed that 
myths and misconceptions about IUCDs were the main 
barriers to their uptake (Mbuthia, 2014). 
The highest proportion of women who sought FP 
services from 2014 to 2017 used injectables and the 
proportion was above 60% in the review period. 
However, the use of injectables had a declining trend 
from 2014 to 2017 despite the number of facilities 
having stock-outs being below 7.7% in the review 
period (Ministry of Health Kenya, 2018). This could be 
attributed to the shift to long-term contraceptive 
methods.  
There was a general decline in the number of all 
contraceptives consumed in July and August 2017. This 
could be attributed to the national wide nurse’s strike 
that affected the public sector health facilities service 
delivery. The Kenya public sector experienced several 
industrial strikes by health workers since devolution in 
2013. The nurse's strike had a major impact on the 
provision of family planning services in the health 
facilities, as they are the primary service providers. 
There were several strikes by nurses in the country and 
various counties during the period of evaluation. In 
2014 and 2015, several counties experienced industrial 
disputes by nurses such as Nandi, Mombasa, Homabay, 
Kilifi, Kericho, Vihiga, Siaya and Kakamega.  
The concurrent strike by doctors in December 2016 for 
three months affected the supply of contraceptives as 
pharmacists are tasked with reporting and ordering of 
contraceptives at the sub-county and county levels. A 
study that was done in 2015 to review the effect of 
industrial actions by nurses at Rift Valley Provincial 
General Hospital- Nakuru showed that strikes greatly 
affected service delivery in the hospital. Strikes led to 
shutting down of hospitals and turning away of clients 
at the hospital (Shitsinzi, 2015). 
Correlation between consumption data and service data 
for injectables, IUCDs, and implants revealed 
discrepancies in the quantities reported. The difference 
could be partially accounted for by losses and expiries 
but they were minimal. This could also be attributed to 
errors in reporting the service data or consumption 
data. Ideally, the consumption data and service data 
should be the same for contraceptives issued per piece 
or unit, which is the case for injectables, implants and 
intrauterine contraceptives devices after accounting for 
losses. This showed that there was a gap in the 
reporting of contraceptives in the facilities hence need 
for capacity building to bridge the gap. 
The exponential smoothing model was the best suited 
for forecasting consumption of injectables, COCs, IUCDs, 
POPs, and two-rod implants. The ARIMA models were 
suitable for forecasting one-rod implants. The models 
chosen had the lowest mean absolute percentage error, 
root means squared error and mean absolute scale 
error for all the contraceptives evaluated for the six 
months forecasting interval (Hyndman and 
Athanasopoulos, 2018).   
The exponential smoothing model is therefore 
applicable in short term forecasting of contraceptives 
consumption for public sector in Kenya. The time series 
method can be used to study patterns of contraceptive 
use hence informing the method mix during forecasting 
and procurement. 
5.0 Conclusion  
There was a general shift in the use of modern 
contraceptives from short term to long term acting 
reversible methods. This was shown by the decline in 
the use of pills and injectables and the increase in the 
use of implants. The consumption was greatly affected 
by the availability of methods and services at the 
providing facilities. It is therefore important to ensure 
constant and timely supply of contraceptives in the 
facilities. There was a significant difference between the 
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reported consumption data and service point data for 
injectables, implants and more so the intrauterine 
contraceptive devices. The exponential smoothing 
model was the most suitable for forecasting 
consumption of contraceptives. 
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